257 related articles for article (PubMed ID: 17436040)
1. Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease.
Petersen AM; Penkowa M; Iversen M; Frydelund-Larsen L; Andersen JL; Mortensen J; Lange P; Pedersen BK
Lung; 2007; 185(3):161-71. PubMed ID: 17436040
[TBL] [Abstract][Full Text] [Related]
2. Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients.
Rabinovich RA; Figueras M; Ardite E; Carbó N; Troosters T; Filella X; Barberà JA; Fernandez-Checa JC; Argilés JM; Roca J
Eur Respir J; 2003 May; 21(5):789-94. PubMed ID: 12765422
[TBL] [Abstract][Full Text] [Related]
3. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
Ju CR; Chen RC
Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
[TBL] [Abstract][Full Text] [Related]
4. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
5. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
[TBL] [Abstract][Full Text] [Related]
6. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle inflammation and nitric oxide in patients with COPD.
Montes de Oca M; Torres SH; De Sanctis J; Mata A; Hernández N; Tálamo C
Eur Respir J; 2005 Sep; 26(3):390-7. PubMed ID: 16135718
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
9. Decreased exercise-induced expression of nuclear factor-κB-regulated genes in muscle of patients with COPD.
Mercken EM; Hageman GJ; Langen RC; Wouters EF; Schols AM
Chest; 2011 Feb; 139(2):337-346. PubMed ID: 20688919
[TBL] [Abstract][Full Text] [Related]
10. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
12. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD.
Remels AH; Schrauwen P; Broekhuizen R; Willems J; Kersten S; Gosker HR; Schols AM
Eur Respir J; 2007 Aug; 30(2):245-52. PubMed ID: 17459894
[TBL] [Abstract][Full Text] [Related]
14. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 production and pulmonary function in COPD.
Imaoka H; Hoshino T; Takei S; Kinoshita T; Okamoto M; Kawayama T; Kato S; Iwasaki H; Watanabe K; Aizawa H
Eur Respir J; 2008 Feb; 31(2):287-97. PubMed ID: 17989120
[TBL] [Abstract][Full Text] [Related]
16. Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD.
Vogiatzis I; Stratakos G; Simoes DC; Terzis G; Georgiadou O; Roussos C; Zakynthinos S
Thorax; 2007 Nov; 62(11):950-6. PubMed ID: 17573449
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.
Yende S; Waterer GW; Tolley EA; Newman AB; Bauer DC; Taaffe DR; Jensen R; Crapo R; Rubin S; Nevitt M; Simonsick EM; Satterfield S; Harris T; Kritchevsky SB
Thorax; 2006 Jan; 61(1):10-6. PubMed ID: 16284220
[TBL] [Abstract][Full Text] [Related]
18. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
[TBL] [Abstract][Full Text] [Related]
19. [The proteasome inhibitor MG132 attenuates skeletal muscle atrophy in a rat model of chronic obstructive pulmonary disease].
Ma BM; Liu ZH; Liang ZK; Guan LJ; Wang XL
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):441-6. PubMed ID: 24103208
[TBL] [Abstract][Full Text] [Related]
20. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
